Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

SEC Filings

IsoRay, Inc. (NYSEMKT:ISR) Files An 8-K

ITUS Corp (NASDAQ:ITUS) Files An 8-K

Iteris Inc (NASDAQ:ITI) Files An 8-K

iCAD Inc (NASDAQ:ICAD) Files An 8-K

Enduro Royalty Trust (NYSE:NDRO) Files An 8-K

Endo International Plc (NASDAQ:ENDP) Files An 8-K

Everyday Health, Inc. (NYSE:EVDY) Files An 8-K

Erie Indemnity Company (NASDAQ:ERIE) Files An 8-K

Diamondback Energy, Inc. (NASDAQ:FANG) Files An 8-K

Donegal Group Inc. (NASDAQ:DGICA) Files An 8-K

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY